Skip to main content

Monkeypox clinical trials at UCSF

1 in progress, 0 open to eligible people

Showing trials for
  • Study of Tecovirimat for Human Monkeypox Virus

    Sorry, not currently recruiting here

    A5418 is a randomized, placebo-controlled, double-blind study to establish the efficacy of tecovirimat for the treatment of people with laboratory-confirmed or presumptive HMPXV disease.

    San Francisco, California and other locations

Last updated: